Cognitive Effects of Antipsychotic Medications in Schizophrenia

Summary

Antipsychotic medications are the cornerstone of schizophrenia treatment, primarily targeting positive symptoms via dopamine D2 receptor antagonism or partial agonism. However, cognitive impairment—encompassing attention, processing speed, working memory, verbal learning and executive function—remains the principal predictor of functional outcome and quality of life. Research has delineated both beneficial and adverse cognitive effects of antipsychotics. Some agents may stabilise or modestly improve processing speed and attentional control, while others, particularly those with high anticholinergic properties or high dopamine blockade, can exacerbate deficits in verbal memory, learning and executive functioning. The balance between therapeutic efficacy and cognitive side effects is influenced by polypharmacy, cumulative dose exposure and individual patient factors such as age, stage of illness and concomitant medications. Emerging mechanistic studies highlight the role of subcortical dopamine pathways in cognitive processes and suggest that anticholinergic burden may be a key mediator of iatrogenic impairment. Global implications of these findings include the optimisation of dose regimens, the choice of agents with lower anticholinergic profiles and integration of cognitive remediation strategies to mitigate treatment-related decline.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Cognitive Effects of Antipsychotic Medications in Schizophrenia publication trend

The graph below shows the total number of articles in cognitive effects of antipsychotic medications in schizophrenia across all publications each year (not limited to Nature Index journals).

Technical terms

Working memory: The system for temporarily holding and manipulating information during complex tasks.

Executive function: Cognitive processes including planning, cognitive flexibility and inhibitory control.

Anticholinergic burden: Cumulative effect of medications that block acetylcholine receptors, often impairing attention and memory.

Chlorpromazine equivalent: Standardised measure to compare the potency of different antipsychotics based on chlorpromazine dosage.

D2 receptor occupancy: Proportion of dopamine D2 receptors bound by an antipsychotic, influencing both therapeutic and cognitive effects.

References

  1. Effects of risperidone/paliperidone versus placebo on cognitive functioning over the first 6 months of treatment for psychotic disorder: secondary analysis of a triple-blind randomised clinical trial. Translational Psychiatry (2023).
  2. Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment in schizophrenia: results from the multicenter FACE-SZ cohort. Frontiers in Pharmacology (2024).
  3. Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia. BMC Psychiatry (2023).
  4. Subcortical Dopamine and Cognition in Schizophrenia: Looking Beyond Psychosis in Preclinical Models. Frontiers in Neuroscience (2020).
Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.